Mar 21, 2025, 08:29 by

European women will soon be able to receive permanent birth control through a non-surgical approach. FemBloc, developed by Femasys, a leading biomedical innovator addressing significant unmet needs in women's health worldwide, announces Conformité Européene (CE) mark certification under the European Union Medical Device Regulation (EU MDR) as the first regulatory approval in the world for the FemBloc® delivery system for non-surgical female permanent birth control.

Mar 21, 2025, 08:29 by

Coronado Research has appointed Gary Lyons as EVP Medical Affairs. Gary is a seasoned senior Medical Affairs leader with extensive strategic and operational implementation experience across the industry and product lifecycle.

Mar 20, 2025, 08:27 by

CariGenetics and Oxford Nanopore Technologies have launched the Caribbean Genome Programme, the first large-scale genomic sequencing initiative in the region. This pioneering effort is set to address unmet need in advancing regional genetic research in the Caribbean, providing real-time, high throughput sequencing to address critical health disparities, starting with men’s health.

Mar 20, 2025, 01:00 by User Not Found

Clinical Research News | Flatiron Health is breaking new ground in oncology research by enabling patient-level real-world data (RWD) sharing across four countries—U.S., UK, Germany, and Japan. Despite initial skepticism, researchers are now eager to access these harmonized electronic health record (EHR) datasets in a secure, cloud-based environment.

Mar 18, 2025, 08:25 by

START's site network solidifies its global leadership in urological cancer trials.

Mar 18, 2025, 01:00 by User Not Found

Clinical Research News | For medical oncologists, the clinical quandary in treating patients is whether a newly marketed agent or drug cocktail will work as well as it did for the average cancer patient in a landmark clinical trial.

Mar 14, 2025, 08:07 by

Coronado Research has appointed Nick Littlebury as EVP, Regulatory Affairs. Nick is a senior regulatory leader with extensive strategic and operational experience across the pharmaceutical industry's product lifecycle.

Mar 14, 2025, 01:00 by User Not Found

Clinical Research News | Interest in Real-World Evidence (RWE) studies continues to grow. Data from ClinicalTrials.gov shows the number of RWE studies registered has increased dramatically since 2005, particularly in the last seven years. But what is RWE, how is it used in clinical trials and how can we work with Real-World Data (RWD) to produce RWE?

Mar 12, 2025, 13:21 by

The Biotech Roadshow: Shaping the Future of Clinical Trials with Expert Insights will take place in person on Tuesday, 25th March at Alderley Park, Macclesfield, UK from 10 am to 2 pm

Mar 12, 2025, 08:33 by

Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD

Mar 12, 2025, 08:33 by

Qureight Ltd. and Remedy Cell are integrating the latest AI deep learning technology into a Phase 1b study of RC-0315, to develop a novel therapy for the fatal lung condition Idiopathic Pulmonary Fibrosis (IPF).

Mar 12, 2025, 01:00 by User Not Found

Clinical Research News | Jumo Health launched a suite of services to drive health equity in clinical trials in 2023 via a collaboration with I Choose Life Foundation, a nonprofit dedicated to addressing health disparities in the African American community. It helped the company pilot its first community engagement event in the form of a workshop to train local business and faith leaders to serve as trusted messengers of information about clinical research and the point-of-care experience.

Mar 11, 2025, 01:00 by User Not Found

Clinical Research News | For Black women diagnosed with breast cancer, the grim reality is that they are 41% more likely to die of the disease than white women. African American women are disproportionately affected by triple negative breast cancer (TNBC), the most aggressive form of the disease, but that only partially explains the discrepancy in the mortality rate.

Mar 6, 2025, 01:00 by User Not Found

Clinical Research News | In this month’s episode of the Scope of Things, host Deborah Borfitz delivers the news on how an AI-powered trial screening tool outperformed human research staff, a strategy report on boosting cancer vaccine work, the issue of continued absence of pregnant women in clinical trials, and more. Plus, Rare Patient Voice founder and president Wes Michael also joins in to talk about how his company is connecting people undertaking research studies with participants eager to share their insights.

Mar 5, 2025, 08:15 by

Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link.

Mar 4, 2025, 01:00 by User Not Found

Clinical Research News | Generative artificial intelligence is being used by AstraZeneca to expedite its five-year ambitions to be an $80 billion company, deliver 20 new medicines, and be carbon negative. The initial value-driving activities include the creation of AI assistants to help with 3D location detection on CT scans and facilitate knowledge extraction for clinical documents as well as an intelligent protocol tool built in partnership with medical writers.

Mar 3, 2025, 08:22 by

Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research.

Feb 28, 2025, 07:58 by

TrialValue, a platform by RHIEOS Ventures Ltd (UK), has launched a groundbreaking human-augmented analytics intelligence budget prediction engine for clinical trials. Originally developed in 2018 using machine learning, curated datasets, and real-world data, this innovation generates full trial budgets with minimal assumptions, offering speed, confidence, and accuracy. The tool provides financial optimization recommendations and empowers stakeholders to make informed decisions. Larry Ajuwon, Director of RHIEOS Ventures, calls it “TrialValue Clinical R&D Financial Benchmarking’s new deal.” TrialValue aims to enhance financial efficiency in clinical development, reducing delays and uncertainties.

Feb 27, 2025, 10:29 by

Company prioritizes efficiency through innovation with new embedded AI and automation platform capabilities, including a GenAI-Powered Chatbot and Clean Progress Tracking

Feb 27, 2025, 09:36 by User Not Found

Clinical Research News | Thermo Fisher Scientific launched the CorEvitas Systemic Lupus Erythematosus (SLE) Registry; MedTech Innovator announced new industry partners; Seonix Bio announced the US launch of SightScore for primary open-angle glaucoma; and more.